RIPK-IN-4
RIPK-IN-4 is a selective RIPK2 inhibitor with an IC50 value of 3 nM. RIPK-IN-4 can be used for the research of inflammatory diseases[1].
Product Specifications
CAS Number
2141969-56-2
UNSPSC
12352005
Target
RIP kinase
Type
Reference compound
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/ripk-in-4.html
Concentration
10mM
Purity
99.57
Solubility
DMSO : 31.25 mg/mL (ultrasonic)
Smiles
O=S(C1=CN2C(C3=CC(N)=NC(F)=C3)=CN=C2C=C1OCC)(C(C)(C)C)=O
Molecular Formula
C18H21FN4O3S
Molecular Weight
392.45
References & Citations
[1]He X, et al. Identification of Potent and Selective RIPK2 Inhibitors for the Treatment of Inflammatory Diseases. ACS Med Chem Lett. 2017 Sep 27;8 (10) :1048-1053.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
RIPK2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6268461-01 0.1 mL
CD36 (CD36 Antigen, Fatty Acid Translocase, FAT, Glycoprotein IIIb, gpIIIb, gp3b, gpIV, gp4, Leukocyte Differentiation Antigen CD36, PAS-4 Protein, PAS-IV, PASIV, Platelet Collagen Receptor, Platelet Glycoprotein 4, Platelet Glycoprotein IV, Scarb3, Throm
Sign In for Pricing
View Details MBS6268461-02 5x 0.1 mL
CD36 (CD36 Antigen, Fatty Acid Translocase, FAT, Glycoprotein IIIb, gpIIIb, gp3b, gpIV, gp4, Leukocyte Differentiation Antigen CD36, PAS-4 Protein, PAS-IV, PASIV, Platelet Collagen Receptor, Platelet Glycoprotein 4, Platelet Glycoprotein IV, Scarb3, Throm
Sign In for Pricing
View Details